About Us

Advancing Precision Genetic Therapies With the Potential to Restore, Improve and Preserve Hearing

Listening is in our DNA.

Ακούω in Greek translates to Listen in English. At Akouos (ah KOO ohs), we strive to be a team that listens to one another, to healthcare providers, and to the deaf and hard of hearing (D/HH) community. Our partnerships and collaborations are focused on common goals and predicated on respect, trust, and transparency.

Common Goal Partnerships

In partnering with the D/HH community, we will use the principles outlined here as our guide.

Hearing loss is one of the greatest challenges in medicine today, and with no FDA-approved pharmacologic therapies available, an area of severe unmet need.

Manny Simons, PH.Dfounder and CEO of Akouos

We Are Akouos

  • Filter By:

  • Cambria Alpha-Cobb

    LEGAL

  • Ryan Anderson

    ANATOMY & PHYSIOLOGY

  • Yukako Asai

    ANATOMY & PHYSIOLOGY

  • Priya Bansode

    AAV MOLECULAR BIOLOGY

  • Mike Bayer

    TECHNICAL OPERATIONS

  • Jean Bennett

    SCIENTIFIC ADVISORY BOARD

  • Alexandra Bettina

    REGULATORY AFFAIRS

  • Liz Bougoulas

    FINANCE

  • Frima Bourtman

    PROGRAM MANAGEMENT

  • Timothy Boyd

    PROCESS & ANALYTICAL DEVELOPMENT

  • Joshua Boyer

    CLINICAL DEVELOPMENT

  • Amy Burke

    CLINICAL DEVELOPMENT

  • Bethany Calagione

    LEGAL

  • Robyn Chiang

    AAV MOLECULAR BIOLOGY

  • Rick Churchill

    AAV MOLECULAR BIOLOGY

  • Jason Connell

    IT

  • John Dadurian

    FINANCE

  • Michelle Dang

    PROCESS & ANALYTICAL DEVELOPMENT

  • Samantha Davis

    ANATOMY & PHYSIOLOGY

  • Stephen DiRico

    TECHNICAL OPERATIONS

  • Sara Donaldson

    QUALITY

  • Adeana Dorsey

    REGULATORY AFFAIRS

  • Jamie Estime

    QUALITY

  • Yi Feng

    TRANSLATIONAL MEDICINE

  • Shimon Francis

    ANATOMY & PHYSIOLOGY

  • Yuan Gao

    ANATOMY & PHYSIOLOGY

  • Alan Gilstrap

    ADVOCACY & ENGAGEMENT

  • Aaron Graham

    QUALITY

  • Katherine Gribble

    AAV MOLECULAR BIOLOGY

  • Karen Grinnen

    CLINICAL DEVELOPMENT

  • Lakeija Hall

    OFFICE MANAGEMENT

  • Tyler Halloran

    CLINICAL DEVELOPMENT

  • Christian Heath

    OPERATIONS

  • Joey Henry

    ANATOMY & PHYSIOLOGY

  • Amanda Henry

    QUALITY

  • Linnea Herzog

    ANATOMY & PHYSIOLOGY

  • Ann Hickox

    REGULATORY AFFAIRS

  • Eric Horowitz

    PROCESS & ANALYTICAL DEVELOPMENT

  • Veronica Juarez

    PROGRAM LEAD

  • Arlene Juaton

    QUALITY

  • Judith Kelley

    EXECUTIVE ADMINISTRATION

  • Ian Kenney

    TECHNICAL OPERATIONS

  • Sayou Ketcha

    PROCESS & ANALYTICAL DEVELOPMENT

  • Prarthana Khanna

    BUSINESS DEVELOPMENT

  • Ventsi Kichikov

    IT

  • Ye-Hyun Kim

    ANATOMY & PHYSIOLOGY

  • Brian Krisak

    PROGRAM MANAGEMENT

  • Kathy Lennon

    CLINICAL

  • Danielle Lenz

    AAV MOLECULAR BIOLOGY

  • Brian Lin

    MEDICAL

  • Emily Liu

    CLINICAL DEVELOPMENT

  • Todd Mabe

    QUALITY

  • Donna Mackey

    CLINICAL DEVELOPMENT

  • John Martin

    TECHNICAL OPERATIONS

  • Alex Martinez

    ANATOMY & PHYSIOLOGY

  • Ed Mathers

    BOARD OF DIRECTORS

  • Sam Maxwell

    PROCESS & ANALYTICAL DEVELOPMENT

  • Heather McCormick

    QUALITY

  • Michael McKenna

    CHIEF MEDICAL OFFICER & CO-FOUNDER

  • Jennifer Meaney

    HUMAN RESOURCES

  • Laura Melville

    EXECUTIVE ADMINISTRATION

  • Garo Mikaelian

    TECHNICAL OPERATIONS

  • Nancy Miller

    QUALITY

  • Sachiyo Minegishi

    CHIEF FINANCIAL OFFICER

  • Joe Mombeleur

    PROCESS & ANALYTICAL DEVELOPMENT

  • Lee-Ann Murphy

    COMMUNICATIONS

  • Robert Ng

    AAV MOLECULAR BIOLOGY

  • Michael Nguy

    PROCESS DEVELOPMENT

  • Kenyaria Nobl

    ANATOMY & PHYSIOLOGY

  • Brian O’Neil

    OPERATIONS

  • Damla Ozen

    IT

  • Alix Pagliarini

    HUMAN RESOURCES

  • Bifeng Pan

    ANATOMY & PHYSIOLOGY

  • Kush Parmar

    BOARD OF DIRECTORS

  • Jean Phillips

    CLINICAL

  • Marshall Poirier

    PROCESS DEVELOPMENT

  • Kevin Powers

    QUALITY

  • Heather Preston

    BOARD OF DIRECTORS

  • Stacy Price

    CHIEF TECHNICAL OFFICER

  • Saira Ramasastry

    BOARD OF DIRECTORS

  • Kathy Reape

    CHIEF DEVELOPMENT OFFICER

  • Elena Saenko

    FINANCE

  • Jennifer Santos

    ANATOMY & PHYSIOLOGY

  • Vicki Sato

    BOARD OF DIRECTORS

  • William Sewell

    FOUNDER

  • Karoline Shair

    CHIEF LEGAL OFFICER & CORPORATE SECRETARY

  • Rita Simonds

    QUALITY

  • Emmanuel Simons

    CEO, PRESIDENT & CO-FOUNDER

  • Chris Smith

    BOARD OF DIRECTORS

  • Richard Smith

    FOUNDER

  • Jenna Soper

    PROGRAM MANAGEMENT

  • Jay Stella

    SVP, CORPORATE STRATEGY

  • Suzanne Stokes

    PROGRAM LEAD

  • Christian Supina

    REGULATORY AFFAIRS

  • Junaid Syed

    ANATOMY & PHYSIOLOGY

  • Chris Tarapata

    TECHNICAL OPERATIONS

  • Danielle Thompson

    EXECUTIVE ADMINISTRATION

  • Colleen Tucker

    HUMAN RESOURCES

  • Aaron Tward

    CHIEF SCIENTIFIC OFFICER

  • Arthur Tzianabos

    BOARD OF DIRECTORS

  • Michelle Valero

    ANATOMY & PHYSIOLOGY

  • Luk Vandenberghe

    FOUNDER

  • Stephanie Vander Veur

    QUALITY

  • Brian Vincent

    OPERATIONS

  • Katie Wachtel

    REGULATORY AFFAIRS

  • Suzanne Walker

    EXECUTIVE ADMINISTRATION

  • Sierra Wasielewski

    PROCESS DEVELOPMENT

  • Jennifer Wellman

    CHIEF OPERATING OFFICER

  • Brianna Whelan

    OPERATIONS

  • Jonathan Yeh

    PROCESS & ANALYTICAL DEVELOPMENT

Our Partners

Join us in the pursuit of healthy hearing for all.

What’s at our core

We Work to Change Lives

Akouos listens: to each other, to the individuals and families we work to serve, to our collective conscience.
Akouos engages: Honestly, transparently, respectfully.
Akouos leads: Authentically, boldly, bravely, with purpose and passion.
Akouos creates: High standards, opportunities to excel, better medicines.
Akouos trusts: Ourselves, each other, our science.

Join us in the pursuit of healthy hearing for all.

Akouos is building a leading gene therapy company focused on hearing disorders. Our objectives are to restore the inner ear’s ability to produce functional proteins required for hearing, rejuvenate structures of the hearing circuit critical for high-fidelity signal transduction and inner ear homeostasis, and reinforce healthy hearing with local, enduring protein production to protect against drug-, noise-, and age- associated ototoxicity.